High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Krypuy, Michael ^a   Newnham, Genni M ^a,b   Thomas, David M ^a,b   Conron, Matthew ^b,c   Dobrovic, Alexander ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; DYE; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN;

AMPLICON; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER SCREENING; CELL STRAIN HCT116; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EXON; HIGH RESOLUTION MELTING ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MUTATIONAL ANALYSIS; RELIABILITY; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SOMATIC MUTATION;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CODON; DNA, NEOPLASM; HUMANS; LUNG NEOPLASMS; MUTATION; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 33846641709     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-295     Document Type: Article

References (62)

1. Wittwer CT Reed GH Gundry CN Vandersteen JG Pryor RJ High-resolution genotyping by amplicon melting analysis using LCGreen Clin Chem 2003 49(6 Pt 1) 853-860 10.1373/49.6.853 12765979
2. Der CJ Krontiris TG Cooper GM Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses Proc Natl Acad Sci U S A 1982 79(11) 3637-3640 346478 6285355 10.1073/pnas.79.11.3637
3. Bos JL ras oncogenes in human cancer: A review Cancer Res 1989 49(17) 4682-4689 2547513
4. Adjei AA Blocking oncogenic Ras signaling for cancer therapy J Natl Cancer Inst 2001 93(14) 1062-1074 10.1093/jnci/93.14.1062 11459867
5. Gazdar AF Shigematsu H Herz J Minna JD Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? Trends Mol Med 2004 10(10) 481-486 10.1016/j.molmed.2004.08.008 15464447
6. Marchetti A Martella C Felicioni L Barassi F Salvatore S Chella A Camplese PP Iarussi T Mucilli F Mezzetti A EGFR mutations in non-small-cell lung cancer: Analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment J Clin Oncol 2005 23(4) 857-865 10.1200/JCO.2005.08.043 15681531
7. Lynch TJ Bell DW Sordella R Gurubhagavatula S Okimoto RA Brannigan BW Harris PL Haserlat SM Supko JG Haluska FG Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 2004 350(21) 2129-2139 10.1056/NEJMoa040938 15118073
8. Paez JG Janne PA Lee JC Tracy S Greulich H Gabriel S Herman P Kaye FJ Lindeman N Boggon TJ EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy Science 2004 304 5676 1497-1500 10.1126/science.1099314 15118125
9. Pao W Miller V Zakowski M Doherty J Politi K Sarkaria I Singh B Heelan R Rusch V Fulton L EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci U S A 2004 101 36 13306-13311 516528 15329413 10.1073/pnas.0405220101
10. Pao W Wang TY Riely GJ Miller VA Pan Q Ladanyi M Zakowski MF Heelan RT Kris MG Varmus HE KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib PLoS Med 2005 2 1 e17 545207 15696205 10.1371/journal.pmed.0020017
11. Tsao MS Sakurada A Cutz JC Zhu CQ Kamel-Reid S Squire J Lorimer I Zhang T Liu N Daneshmand M Erlotinib in lung cancer - molecular and clinical predictors of outcome N Engl J Med 2005 353 2 133-144 10.1056/ NEJMoa050736 16014883
12. Sasaki H Endo K Mizuno K Yano M Fukai I Yamakawa Y Fujii Y EGFR mutation status and prognosis for gefitinib treatment in Japanese lung cancer Lung Cancer 2006 51 1 135-136 10.1016/j.lungcan.2005.09.004 16314000
13. Keohavong P DeMichele MA Melacrinos AC Landreneau RJ Weyant RJ Siegfried JM Detection of K-ras mutations in lung carcinomas: Relationship to prognosis Clin Cancer Res 1996 2 2 411-418 9816185
14. Huang CL Taki T Adachi M Konishi T Higashiyama M Kinoshita M Hadama T Miyake M Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer Int J Oncol 1998 12 3 553-563 9472092
15. Graziano SL Gamble GP Newman NB Abbott LZ Rooney M Mookherjee S Lamb ML Kohman LJ Poiesz BJ Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer J Clin Oncol 1999 17 2 668-675 10080613
16. Huncharek M Muscat J Geschwind JF K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: A combined analysis of 881 cases Carcinogenesis 1999 20 8 1507-1510 10.1093/carcin/20.8.1507 10426799
17. Nelson HH Christiani DC Mark EJ Wiencke JK Wain JC Kelsey KT Implications and prognostic value of K-ras mutation for early-stage lung cancer in women J Natl Cancer Inst 1999 91 23 2032-2038 10.1093/jnci/ 91.23.2032 10580029
18. Pajkos G Kiss I Sandor J Ember I Kishazi P The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer Anticancer Res 2000 20 3A 1695-1701 10928094
19. Gandara DR Lara PN Lau DH Mack P Gumerlock PH Molecular-clinical correlative studies in non-small cell lung cancer: Application of a three-tiered approach Lung Cancer 2001 34 Suppl 3 S75-80 10.1016/ S0169-5002(01)00368-3 11740998
20. Lievre A Bachet JB Le Corre D Boige V Landi B Emile JF Cote JF Tomasic G Penna C Ducreux M KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer Cancer Res 2006 66 8 3992-3995 10.1158/0008-5472.CAN-06-0191 16618717
21. Hassan AB Paraskeva C Colorectal cancer prognosis: Is it all mutation, mutation, mutation? Gut 2005 54 9 1209-1211 10.1136/gut.2005.070946 16099785
22. Song MM Nio Y Sato Y Tamura K Furuse K Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas Int J Pancreatol 1996 20 2 85-93 8968863
23. Kawesha A Ghaneh P Andren-Sandberg A Ograed D Skar R Dawiskiba S Evans JD Campbell F Lemoine N Neoptolemos JP K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma Int J Cancer 2000 89 6 469-474 10.1002/ 1097-0215(20001120)89:6<469::AID-IJC1>3.0.CO;2-L 11102889
24. Arvanitakis M Van Laethem JL Parma J De Maertelaer V Delhaye M Deviere J Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation Endoscopy 2004 36 6 535-542 10.1055/s-2004-814401 15202051
25. Kim J Reber HA Dry SM Elashoff D Chen SL Umetani N Kitago M Hines OJ Kazanjian KK Hiramatsu SH Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins Gut 2006 55 11 1598-605 10.1136/gut.2005.083063 16682430
26. Suzuki Y Orita M Shiraishi M Hayashi K Sekiya T Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products Oncogene 1990 5 7 1037-1043 2197591
27. Emanuel JR Damico C Ahn S Bautista D Costa J Highly sensitive nonradioactive single-strand conformational polymorphism. Detection of Ki-ras mutations Diagn Mol Pathol 1996 5 4 260-264 10.1097/ 00019606-199612000-00006 8955617
28. Lilleberg SL Durocher J Sanders C Walters K Culver K High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform Ann N Y Acad Sci 2004 1022 250-256 10.1196/ annals.1318.039 15251969
29. Keohavong P Zhu D Whiteside TL Swalsky P Bakker A Elder EM Siegfried JM Srivastava S Finkelstein SD Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues Anal Biochem 1997 247 2 394-403 10.1006/abio.1997.2100 9177704
30. Bjorheim J Lystad S Lindblom A Kressner U Westring S Wahlberg S Lindmark G Gaudernack G Ekstrom P Roe J Mutation analyses of KRAS exon 1 comparing three different techniques: Temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction Mutat Res 1998 403 1-2 103-112 9726011
31. Bjorheim J Ekstrom PO Fossberg E Borresen-Dale AL Gaudernack G Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations Biotechniques 2001 30 5 972-975 11355359
32. Bjorheim J Minarik M Gaudernack G Ekstrom PO Mutation detection in KRAS Exon 1 by constant denaturant capillary electrophoresis in 96 parallel capillaries Anal Biochem 2002 304 2 200-205 10.1006/abio.2002.5629 12009696
33. Apple SK Hecht JR Novak JM Nieberg RK Rosenthal DL Grody WW Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears Am J Clin Pathol 1996 105 3 321-326 8602613
34. Fukayama N Sugano K Kyogoku A Nose H Kondou H Ohkura H [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme] Rinsho Byori 1993 41 9 1017-1023 8254964
35. Ward R Hawkins N O'Grady R Sheehan C O'Connor T Impey H Roberts N Fuery C Todd A Restriction endonuclease-mediated selective polymerase chain reaction: A novel assay for the detection of K-ras mutations in clinical samples Am J Pathol 1998 153 2 373-379 9708798
36. Clayton SJ Scott FM Walker J Callaghan K Haque K Liloglou T Xinarianos G Shawcross S Ceuppens P Field JK K-ras point mutation detection in lung cancer: Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification Clin Chem 2000 46 12 1929-1938 11106325
37. Altavilla G Castellan L Wabersich J Marchetti M Onnis A Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix Eur J Gynaecol Oncol 1996 17 4 267-270 8856301
38. Albitar M Wu WI Feltz E Jin G Hirsch-Ginsberg C Kantarjian H Beran M Simplified Reverse Dot Blot Analyses for Detecting of ras Oncogene Mutations Mol Diagn 1997 2 3 169-176 10.1016/S1084-8592(97)80025-2 10462606
39. Becker CF Hunter CL Seidel RP Kent SB Goody RS Engelhard M A sensitive fluorescence monitor for the detection of activated Ras: Total chemical synthesis of site-specifically labeled Ras binding domain of c-Raf1 immobilized on a surface Chem Biol 2001 8 3 243-252 10.1016/ S1074-5521(01)00003-5 11306349
40. Lleonart ME Ramon y Cajal S Groopman JD Friesen MD Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis Nucleic Acids Res 2004 32 5 e53 390351 15037663 10.1093/nar/gnh051
41. Luo JD Chan EC Shih CL Chen TL Liang Y Hwang TL Chiou CC Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe Nucleic Acids Res 2006 34 2 e12 1345699 16432256 10.1093/nar/gnj008
42. Prix L Uciechowski P Bockmann B Giesing M Schuetz AJ Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool Clin Chem 2002 48 3 428-435 11861435
43. Gonzalez-Cadavid NF Zhou D Battifora H Bar-Eli M Cline MJ Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas Oncogene 1989 4 9 1137-1140 2674856
44. Ogino S Kawasaki T Brahmandam M Yan L Cantor M Namgyal C Mino-Kenudson M Lauwers GY Loda M Fuchs CS Sensitive sequencing method for KRAS mutation detection by Pyrosequencing J Mol Diagn 2005 7 3 413-421 16049314
45. McKinney JT Longo N Hahn SH Matern D Rinaldo P Strauss AW Dobrowolski SF Rapid, comprehensive screening of the human medium chain acyl-CoA dehydrogenase gene Mol Genet Metab 2004 82 2 112-120 10.1016/ j.ymgme.2004.04.004 15171998
46. Reed GH Wittwer CT Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis Clin Chem 2004 50 10 1748-1754 10.1373/clinchem.2003.029751 15308590
47. Willmore-Payne C Holden JA Tripp S Layfield LJ Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis Hum Pathol 2005 36 5 486-493 10.1016/ j.humpath.2005.03.015 15948115
48. Willmore-Payne C Layfield LJ Holden JA c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens Cancer 2005 105 3 165-170 10.1002/cncr.21064 15822120
49. Willmore-Payne C Holden JA Zhou H Gupta D Hirschowitz S Wittwer CT Layfield LJ Evaluation of Her-2/neu gene status in osteosarcoma by fluorescence in situ hybridization and multiplex and monoplex polymerase chain reactions Arch Pathol Lab Med 2006 130 5 691-698 16683887
50. Willmore-Payne C Holden JA Hirschowitz S Layfield LJ BRAF and c-kit gene copy number in mutation-positive malignant melanoma Hum Pathol 2006 37 5 520-527 10.1016/j.humpath.2006.01.003 16647948
51. Willmore-Payne C Holden JA Layfield LJ Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck Mod Pathol 2006 19 5 634-640 10.1038/modpathol.3800552 16547470
52. Willmore-Payne C Holden JA Layfield LJ Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: Correlation with gene copy number, protein expression, and hormone receptor expression Hum Pathol 2006 37 6 755-763 10.1016/ j.humpath.2006.02.004 16733218
53. Willmore-Payne C Holden JA Chadwick BE Layfield LJ Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis Mod Pathol 2006 19 9 1164-9 10.1038/modpathol.3800623 16741525
54. Miller SA Dykes DD Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16 3 1215 334765 3344216 10.1093/nar/16.3.1215
55. Giglio S Monis PT Saint CP Demonstration of preferential binding of SYBR Green I to specific DNA fragments in real-time multiplex PCR Nucleic Acids Res 2003 31 22 e136 275573 14602929 10.1093/nar/gng135
56. Herrmann MG Durtschi JD Bromley LK Wittwer CT Voelkerding KV Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes Clin Chem 2006 52 3 494-503 10.1373/clinchem.2005.063438 16423901
57. Monis PT Giglio S Saint CP Comparison of SYTO9 and SYBR Green I for real-time polymerase chain reaction and investigation of the effect of dye concentration on amplification and DNA melting curve analysis Anal Biochem 2005 340 1 24-34 10.1016/j.ab.2005.01.046 15802126
58. Margraf RL Mao R Highsmith WE Holtegaard LM Wittwer CT Mutation scanning of the RET protooncogene using high-resolution melting analysis Clin Chem 2006 52 1 138-141 10.1373/clinchem.2005.052951 16391329
59. Liew M Pryor R Palais R Meadows C Erali M Lyon E Wittwer C Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons Clin Chem 2004 50 7 1156-1164 10.1373/clinchem.2004.032136 15229148
60. McKinzie PB Parsons BL Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR Mutat Res 2002 517 1-2 209-220 12034322
61. Tan A Westerman D McArthur GA Lynch K Waring P Dobrovic A Sensitive Detection of KIT D816V in Patients with Mastocytosis Clin Chem 2006 52 12 2250-7 10.1373/clinchem.2006.068205 17040960
62. Catalogue Of Somatic Mutations In Cancer (COSMIC) Wellcome Trust Sanger Institute http://www.sanger.ac.uk/genetics/CGP/cosmic/